Search for: "*u.s. v. Noonan" Results 181 - 200 of 482
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 May 2021, 9:59 pm by Patent Docs
Noonan -- Last month, the Federal Circuit affirmed an exclusion order imposed by the International Trade Commission against Bio-Rad for importing infringing microfluidic systems and components used for gene sequencing or related analyses, in Bio-Rad Laboratories, Inc. v. [read post]
14 Feb 2019, 9:50 pm by Patent Docs
Noonan -- Earlier this month, the Federal Circuit affirmed a decision by the Patent Trial and Appeal Board (PTAB) that the claims of U.S. [read post]
17 Apr 2012, 9:59 pm by Patent Docs
Noonan -- In a decision ripe for Supreme Court review (appropriately, this time), a fractured Federal Circuit delivered a plurality opinion in Marine Polymer Technologies, Inc. v. [read post]
19 May 2015, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit affirmed a decision by the U.S. [read post]
20 May 2021, 9:14 pm by Patent Docs
Noonan -- The Federal Circuit continues its recent run of decisions extending the reach of the enablement requirement of 35 U.S.C. 112(a) to invalidate patents in Pacific Biosciences of California, Inc. v. [read post]
16 May 2019, 8:55 pm by Patent Docs
Noonan -- The Federal Circuit exhibited the current status of its obviousness jurisprudence in affirming the District Court's determination that the asserted claims of U.S. [read post]
26 Feb 2019, 9:54 pm by Patent Docs
The case arose over patent infringement brought by the University of Florida Research Foundation (UFRF) against General Electric (GE) over U.S. [read post]
21 May 2018, 9:46 pm by Patent Docs
Noonan -- Last week, the Federal Circuit found all patent claims invalid for obviousness in an inter partes review, in Praxair Distribution, Inc. v. [read post]
20 Aug 2019, 9:59 pm by Patent Docs
Noonan -- Last week, the Federal Circuit reversed findings of non-obviousness and affirmed (over Chief Judge Prost's dissent) a finding that claims asserted in ANDA litigation were not invalid for failure to satisfy the written description requirement in Nalproprion Pharmaceuticals, Inc. v. [read post]
27 Jul 2016, 9:18 pm by Patent Docs
Noonan -- The Federal Circuit affirmed the decision by the Patent Trial and Appeals Board (PTAB) in an inter partes review (IPR) that the claims of Genzyme's U.S Patent Nos. 7,351,410 and 7,655,226 were obvious, in Genzyme Therapeutic Products, Inc. v. [read post]
26 Mar 2023, 9:07 pm by Patent Docs
Noonan -- The Supreme Court's decision to grant certiorari in Amgen v. [read post]